1. Home
  2. CARG vs NUVB Comparison

CARG vs NUVB Comparison

Compare CARG & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CarGurus Inc.

CARG

CarGurus Inc.

HOLD

Current Price

$34.41

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.58

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CARG
NUVB
Founded
2005
2018
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.9B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
CARG
NUVB
Price
$34.41
$4.58
Analyst Decision
Buy
Strong Buy
Analyst Count
12
9
Target Price
$38.29
$11.22
AVG Volume (30 Days)
1.6M
4.8M
Earning Date
05-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
675.00
N/A
EPS
1.55
N/A
Revenue
$316,861,000.00
N/A
Revenue This Year
$11.80
$182.76
Revenue Next Year
$7.89
$91.83
P/E Ratio
$21.70
N/A
Revenue Growth
59.92
N/A
52 Week Low
$24.65
$1.57
52 Week High
$39.42
$9.75

Technical Indicators

Market Signals
Indicator
CARG
NUVB
Relative Strength Index (RSI) 64.11 32.44
Support Level $33.31 $3.92
Resistance Level $36.23 $5.55
Average True Range (ATR) 1.54 0.35
MACD 0.88 -0.06
Stochastic Oscillator 91.54 20.37

Price Performance

Historical Comparison
CARG
NUVB

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: